2-(Tert-butoxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

(4-Fluorophenyl)methanamine hydrochloride, 97%, 5g

2-Chloro-3-methyl-5-nitropyridine, 98.0%, 1g

n-Valeraldehyde, min. 96.5%, 100 ml, glass packaging

(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol, 97%, 1g

Ethyl 2-cyclohexylideneacetate, 95.0%, 10g

3-(Boc-Amino)propyl bromide, 97.0%, 500g

{3-[5-(chloromethyl)-2-methanesulfonyl-1H-imidazol-1-yl]propyl}dimethylamine, 95.0%, 2g

2-ETHYL-2-OXAZOLINE, 95%, 5g

3-Chloro-6-methylpicolinonitrile, 95%, 250mg

2-Methyl-1-(thiophen-3-yl)propan-2-ol, 98%, 10g

Ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate, 98%, 250mg

1-(5-CHLORO-THIOPHEN-3-YL)ETHANOL, 95.0%, 10g